Light-activated drugs


La Vanguardia reports on the research performed by Ernest Giralt and Pau Gorostiza in a collaboration project between IRB Barcelona and IBEC. Published in the German journal Angewandte Chemie, the study describes how the scientists have designed peptides that can be controlled through exposure to light. This breakthrough in chemical nanobioengineering may allow the future development of drugs that can be activated in specific parts of the body and at given times, thus reducing their side-effects.

More information in the press release.

Read the article in La Vanguardia (PDF in Catalan, PDF in Spanish).